In carrying out checks on the application of the provisions of Title II of Book I of Part I and the regulatory measures taken for its application falling within the remit of the Agence nationale de sécurité du médicament et des produits de santé defined in Article L. 5311-1, the Agency’s inspectors have access to the file provided for in Article L. 1121-16.